Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.

Song CH, Fan X, Exeter CJ, Hess EJ, Jinnah HA.

Neurobiol Dis. 2012 Oct;48(1):66-78. doi: 10.1016/j.nbd.2012.05.009.

Task specific focal hand dystonia: understanding the enigma and current concepts.

Potter P.

Work. 2012;41(1):61-8. doi: 10.3233/WOR-2012-1261. Review.

Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study.

Opavský R, Hluštík P, Otruba P, Kaňovský P.

Int J Neurosci. 2012 Jan;122(1):45-52. doi: 10.3109/00207454.2011.623807.

Treatment of focal dystonia.

Batla A, Stamelou M, Bhatia KP.

Curr Treat Options Neurol. 2012 Jun;14(3):213-29. doi: 10.1007/s11940-012-0169-6.

Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Saunders-Pullman R, Raymond D, Stoessl AJ, Hobson D, Nakamura K, Pullman S, Lefton D, Okun MS, Uitti R, Sachdev R, Stanley K, San Luciano M, Hagenah J, Gatti R, Ozelius LJ, Bressman SB.

Neurology. 2012 Feb 28;78(9):649-57. doi: 10.1212/WNL.0b013e3182494d51. Erratum in: Neurology. 2012 Mar 27;78(13):1029. Nakamura, T [corrected to Nakamura, K].

Paroxysmal autonomic instability with dystonia after pneumococcal meningoencephalitis.

Safadieh L, Sharara-Chami R, Dabbagh O.

Case Rep Med. 2012;2012:965932. doi: 10.1155/2012/965932.

Bilateral subthalamic nucleus stimulation for generalized dystonia after bilateral pallidotomy.

Fonoff ET, Campos WK, Mandel M, Alho EJ, Teixeira MJ.

Mov Disord. 2012 Oct;27(12):1559-63. doi: 10.1002/mds.25127.

Aripiprazole-induced oculogyric crisis (acute dystonia).

Bhachech JT.

J Pharmacol Pharmacother. 2012 Jul;3(3):279-81. doi: 10.4103/0976-500X.99446.

Botulinum toxin physiology in focal hand and cranial dystonia.

Karp BI.

Toxins (Basel). 2012 Nov 20;4(11):1404-14. doi: 10.3390/toxins4111404. Review.

Assessment of D216H DYT1 polymorphism in a Chinese primary dystonia patient cohort.

Chen Y, Burgunder JM, Song W, Huang R, Shang HF.

Eur J Neurol. 2012 Jun;19(6):924-6. doi: 10.1111/j.1468-1331.2011.03582.x.

Broad spectrum of dystonia associated with a novel thanatosis-associated protein domain-containing apoptosis-associated protein 1 mutation in a Japanese family with dystonia 6, torsion.

Miyamoto R, Ohta E, Kawarai T, Koizumi H, Sako W, Izumi Y, Obata F, Kaji R.

Mov Disord. 2012 Sep 1;27(10):1324-5. doi: 10.1002/mds.25106. No abstract available.

Commentary for oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8"."

Frucht S.

Mov Disord. 2012 Dec;27(14):1743. doi: 10.1002/mds.25332. No abstract available.

Selective and sustained α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice.

Fan X, Hughes KE, Jinnah HA, Hess EJ.

J Pharmacol Exp Ther. 2012 Mar;340(3):733-41. doi: 10.1124/jpet.111.190082.

Steroid-responsive focal epilepsy with focal dystonia accompanied by glutamate receptor delta2 antibody.

Matsumoto H, Okabe S, Hirakawa-Yamada M, Takahashi Y, Satoh N, Igeta Y, Hashida H.

J Neuroimmunol. 2012 Aug 15;249(1-2):101-4. doi: 10.1016/j.jneuroim.2012.04.009.

Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials.

Chinnapongse RB, Lew MF, Ferreira JJ, Gullo KL, Nemeth PR, Zhang Y.

Clin Neuropharmacol. 2012 Sep-Oct;35(5):215-23. doi: 10.1097/WNF.0b013e318263163c.